Dr. Ted Lithgow
MeadWestvaco Corporation
Healthcare
Career History
Dr. Ted Lithgow, 55, is the president of MWV Healthcare. He is responsible for setting direction, and facilitating commercial strategy and implementation for all MWV products targeted for pharmaceutical customers and healthcare professionals.
Prior to joining MWV, Dr. Lithgow served as senior commercial lead and representative of global prescription pharmaceutical (GPB) development programs, with additional responsibility for all cross-customer and divisional initiatives and processes at Schering-Plough. He was a member of the Global Business Management Team, the corporation’s Research Leadership Committee, the Exploratory Development Committee, and Pharmaceutical Leadership Board governing bodies. Prior to Schering-Plough, Dr. Lithgow served as president of commercial operations and emerging technologies at Pharmacia Corporation. director of new products marketing, global CNS, psychiatry and neurology at Wyeth Corporation and previous director, US women’s health care, prescription therapeutics, contraception, and reproductive disorders. Dr. Lithgow's extensive OTC experience includes R&D project management, project leader of the Zantac 75 OTC Launch Team for the former Warner Wellcome Division of Pfizer Pharmaceuticals; senior product manager for Lubriderm Lotion brands and Neosporin First Aid; and team lead of Improved Rolaids Team, Adams Brands.
Education
- The City University of New York
Doctor of Psychopharmacology - The City University of New York
Master of Philosophy, Biopsychology - Muhlenberg College
Bachelor of Biology, Psychology